Science

Feb 25, 2025, 10:15

Myeloma Paper of the Day, February 25th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Post hoc analysis of large Phase 3 (BMT CTN 0702) demonstrates removing urine assessments from IMWG response criteria changed assessments for only 1.1% of patients, and had no appreciable impact on PFS.”

“Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702”

Authors: Rahul Banerjee, Amber Fritz, Othman Akhtar, Edward Stadtmauer, Marcelo Pasquini et al.

More posts featuring Robert Orlowski.

Amber Fritz cancer Edward Stadtmauer Marcelo Pasquini multiple myeloma Myeloma Paper of the Day OncoDaily Oncology Othman Akhtar Rahul Banerjee Robert Orlowski

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC